Skip to main content
. 2025 Jun 10;13(6):626. doi: 10.3390/vaccines13060626
HCMV Human cytomegalovirus
ANOVA Analysis of variance
ARPE Arising retinal pigment epithelia
ATCC American type culture collection
Chrom Chromatography
CO2 Carbon dioxide
CV CV
Cpw Cells per well
DAPI 4′,6-diamidino-2-phenylindole
DMEM/F-12 Dulbecco’s Modification of Eagle’s Medium and Ham’s F-12 nutrient
DNA Deoxyribonucleic acid
DS Drug substance
DP Drug product
DPI Days post-infection
ED50 Half maximal effective dilution
FBS Fetal bovine serum
FOV Field of view
GFP Green fluorescent protein
gH Glycoprotein H
h Hour
HCMV Human cytomegalovirus
IE1 Immediate Early 1
IU Infectious unit
IRVE Imaging of Relative Viral Expression
IEE Infectivity of Early Gene Expression
Liq Liquid
Lyo Lyophilized
Min Minute
P Passage
PBS Phosphate-buffered saline
PC Positive control
Pen/Strep Penicillin/Streptomycin
PFU Plaque forming unit
RH Relative humidity
rP Relative potency
SD Standard deviation
t Time point
TCID50 Tissue culture infectious dose 50
VCA Variance component analysis
v/v Volume to volume ratio
Wk Week